Expression alterations define unique molecular characteristics of spinal ependymomas

Anbarasu Lourdusamy; Ruman Rahman; Richard G. Grundy

doi:10.18632/oncotarget.3715

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Expression alterations define unique molecular characteristics of spinal ependymomas

Anbarasu Lourdusamy _, Ruman Rahman and Richard G. Grundy

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:19780-19791. https://doi.org/10.18632/oncotarget.3715

Metrics: PDF 2582 views | HTML 2720 views | ?

Abstract

Anbarasu Lourdusamy1, Ruman Rahman1 and Richard G. Grundy1

1 Children’s Brain Tumour Research Centre, School of Medicine, Queen’s Medical Centre University of Nottingham, Nottingham, UK

Correspondence to:

Anbarasu Lourdusamy, email:

Keywords: ependymoma; gene expression; meta-analysis; co-expression network

Received: February 20, 2015 Accepted: March 11, 2015 Published: March 30, 2015

Abstract

Ependymomas are glial tumors that originate in either intracranial or spinal regions. Although tumors from different regions are histologically similar, they are biologically distinct. We therefore sought to identify molecular characteristics of spinal ependymomas (SEPN) in order to better understand the disease biology of these tumors. Using gene expression profiles of 256 tumor samples, we identified increased expression of 1,866 genes in SEPN when compared to intracranial ependymomas. These genes are mainly related to anterior/posterior pattern specification, response to oxidative stress, glial cell differentiation, DNA repair, and PPAR signalling, and also significantly enriched with cellular senescence genes (P = 5.5 × 10-03). In addition, a high number of significantly down-regulated genes in SEPN are localized to chromosome 22 (81 genes from chr22: 43,325,255 – 135,720,974; FDR = 1.77 × 10-23 and 22 genes from chr22: 324,739 – 32,822,302; FDR = 2.07 × 10-09) including BRD1, EP300, HDAC10, HIRA, HIC2, MKL1, and NF2. Evaluation of NF2 co-expressed genes further confirms the enrichment of chromosome 22 regions. Finally, systematic integration of chromosome 22 genes with interactome and NF2 co-expression data identifies key candidate genes. Our results reveal unique molecular characteristics of SEPN such as altered expression of cellular senescence and chromosome 22 genes.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3715

Publication Alerts

Research Papers:

Expression alterations define unique molecular characteristics of spinal ependymomas

Abstract